Clinical trial
Safety and Pharmacokinetics of HU6
NCT05433506
Study timeline
Study start (actual)2022-09-15Date precision: day
Registry last updated2023-03-20
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Obeseunresolved
Interventions
HU6 TabletDRUG
HU6 CapsuleDRUG
Sponsors & collaborators
Rivus Pharmaceuticals, Inc.lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05433506 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.